Nature communications · 2026
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations.
СтатьяМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dai Hongji, Chu Xinlei, Du Han, Yang Shutong, Yao Yanxin, Yu Xinru, Zhao Yanrui, Dong Pei, Lyu Zhangyan, Wang Wei, Li Haixin, Mi Zeyun, Sheng Chao, Li Xiangchun, Zheng Hong, Song Fangfang, Song Fengju, Sun Menghong, Dai Juncheng, Lan Qing, Rothman Nathaniel, Hu Zhibin, Wei Qingyi, Ye Dingwei, Yao Xin, Jia Weihua, Chanock Stephen J, Shen Hongbing, Purdue Mark P, Li Mulin Jun, Chen Kexin
Аннотация
Renal cell carcinoma (RCC) is the most common type of kidney cancer, but its genetic architecture has not been fully characterized, particularly in Asian populations. Here, we perform a multi-ancestry meta-analysis of 33,712 RCC cases and 845,786 controls, including individuals of East Asian (5,313 cases and 96,912 controls), European (25,890 cases and 743,585 controls), African American (897 cases and 3,109 controls), and Latin American ancestry (1,612 cases and 2,180 controls), which unveils 10 novel RCC-associated loci and a Chinese-specific locus at 12p13.33. Leveraging genome-wide association study (GWAS) data and cross-ancestry expression quantitative trait loci (eQTLs) mapping from 266 kidney tissues, we refine the identification of putative causal variants and genes implicated in RCC. These findings are substantiated through CRISPR-based screenings and multiplexed single-cell perturbations. Additionally, we functionally validate a novel association between rs28684409 and the oncogene RPL4 at the complex genetic locus 15q22.31. This comprehensive genetic investigation underscores the utility of integrating cross-ancestry GWASs, QTLs, and functional screens to elucidate the genetic underpinnings of complex diseases.